GLP-1-based polyagonists: A promising weight loss alternative to bariatric surgery

FHS
July 29, 2024
3:51 am

Researchers highlight the unprecedented success of GLP-1-based multi-receptor drugs in achieving substantial weight loss and improved health outcomes, potentially replacing bariatric surgery for obesity treatment.

People with food insecurity deserve better nutrition education

Since spring 2022, a flood of migrants fleeing political instability in Venezuela — about 136,000 — have settled in Queens, New York, and are in

December 27, 2023

4DMT secures rare paediatric designation for cystic fibrosis gene therapy – Pharmaceutical Technology

Share this article Around 40,000 children and adults in the US alone live with the disease that causes severe damage to the lungs. Image credit:

January 24, 2024

Cutting off cancer cells’ access to fats may enhance cancer therapy

Cutting off cancer cells’ access to fat may help a specific type of cancer treatment work more effectively, reports a study by Van Andel Institute

October 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.